These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 2383564

  • 1. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ, Essigmann JM.
    Biochemistry; 1990 Jun 19; 29(24):5872-80. PubMed ID: 2383564
    [Abstract] [Full Text] [Related]

  • 2. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM, Burstyn JN, Essigmann JM, Lippard SJ.
    Biochemistry; 1992 Apr 28; 31(16):3975-90. PubMed ID: 1314653
    [Abstract] [Full Text] [Related]

  • 3. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y, Anin MF, Leng M, Job D.
    Biochemistry; 1992 Feb 25; 31(7):1904-8. PubMed ID: 1536834
    [Abstract] [Full Text] [Related]

  • 4. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J, Brabec V.
    Biochemistry; 1995 Sep 26; 34(38):12379-87. PubMed ID: 7547982
    [Abstract] [Full Text] [Related]

  • 5. Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.
    Bellon SF, Lippard SJ.
    Biophys Chem; 1990 Apr 26; 35(2-3):179-88. PubMed ID: 2397272
    [Abstract] [Full Text] [Related]

  • 6. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
    Naser LJ, Pinto AL, Lippard SJ, Essigmann JM.
    Biochemistry; 1988 Jun 14; 27(12):4357-67. PubMed ID: 3166983
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
    Sundquist WI, Lippard SJ, Stollar BD.
    Proc Natl Acad Sci U S A; 1987 Dec 14; 84(23):8225-9. PubMed ID: 2446320
    [Abstract] [Full Text] [Related]

  • 8. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).
    Bellon SF, Coleman JH, Lippard SJ.
    Biochemistry; 1991 Aug 13; 30(32):8026-35. PubMed ID: 1868076
    [Abstract] [Full Text] [Related]

  • 9. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
    Wei M, Cohen SM, Silverman AP, Lippard SJ.
    J Biol Chem; 2001 Oct 19; 276(42):38774-80. PubMed ID: 11514569
    [Abstract] [Full Text] [Related]

  • 10. Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).
    Yarema KJ, Lippard SJ, Essigmann JM.
    Nucleic Acids Res; 1995 Oct 25; 23(20):4066-72. PubMed ID: 7479066
    [Abstract] [Full Text] [Related]

  • 11. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D, Gaucheron F, Sip M, Leng M.
    Nucleic Acids Res; 1993 Dec 25; 21(25):5846-51. PubMed ID: 8290343
    [Abstract] [Full Text] [Related]

  • 12. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE, Zamble DB, Lippard SJ, Essigmann JM.
    Biochemistry; 1998 Jan 06; 37(1):352-62. PubMed ID: 9425057
    [Abstract] [Full Text] [Related]

  • 13. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS, Sundquist WI, Burstyn JN, Heiger-Bernays WJ, Bellon SF, Ahmed KJ, Amundsen AR, Stern EW, Lippard SJ.
    Cancer Res; 1991 Apr 01; 51(7):1866-75. PubMed ID: 2004370
    [Abstract] [Full Text] [Related]

  • 14. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 15. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA, Lippard SJ.
    Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559
    [Abstract] [Full Text] [Related]

  • 16. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL, Bloemink MJ, Brouwer J, Kidani Y, Reedijk J.
    J Inorg Biochem; 1990 Sep 20; 40(1):23-35. PubMed ID: 2283508
    [Abstract] [Full Text] [Related]

  • 17. A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes.
    Ober M, Lippard SJ.
    J Am Chem Soc; 2008 Mar 05; 130(9):2851-61. PubMed ID: 18269283
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).
    Treiber DK, Zhai X, Jantzen HM, Essigmann JM.
    Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5672-6. PubMed ID: 8202546
    [Abstract] [Full Text] [Related]

  • 19. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH.
    Carcinogenesis; 1985 Apr 07; 6(4):561-6. PubMed ID: 4039227
    [Abstract] [Full Text] [Related]

  • 20. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH, Myint M, Lippard SJ.
    J Am Chem Soc; 2010 Jun 02; 132(21):7429-35. PubMed ID: 20443565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.